The best probiotics for IBS depend on your symptoms. Certain Lactobacillus, Bifidobacterium, and other strains have been studied for IBS-related pain, bloating, diarrhea, or constipation. See which strains, at what doses, and how strong the evidence really is.

White ceramic toilet with an open front toilet seat against a plain background

Overview

  • Irritable Bowel Syndrome (IBS) is a common gut disorder that affects daily life. Symptoms typically include abdominal pain, bloating, diarrhea, and constipation.
  • Probiotics can support gut health when managing IBS symptoms, but the potential benefits will depend on which strain you take.
  • There’s no single best probiotic for IBS. Some strains of Lactobacillus and Bifidobacterium, along with certain synbiotic blends (probiotics + prebiotics), have been studied for their potential to ease common IBS symptoms like inflammation, irregular poop habits, bloating, and gut microbiome imbalances.
  • Looking for probiotics for IBS? Find products with clinically studied strains at effective dosages. Keep in mind that probiotics are transient, meaning they don’t stay in your system forever. Consistent daily intake is key for sustained benefits.
  • If you’re considering taking probiotics for IBS, always talk to your healthcare provider first to make sure it’s suitable for your symptoms and treatment needs.

Dealing with IBS can feel unpredictable, uncomfortable, and sometimes downright disruptive. If you’re experiencing the cramps, bloating, and irregular bowel habits that come with the condition, you’ve likely heard about probiotics—and wondered whether they actually work. 🤔

There’s no single best probiotic for IBS—the evidence is strain- and symptom-specific.

Certain strains and blends may modestly ease specific symptoms. But when researchers pool dozens of trials, the certainty of that evidence is mostly low to very low.1,2

Not all probiotics work the same way, especially for something as complex as IBS. Finding the right one means knowing which strains have actually been studied for your specific symptoms—not just grabbing any bottle off the shelf.

What’s been studied so far, by symptom:

What Is Irritable Bowel Syndrome (IBS)?

According to the American College of Gastroenterology, IBS is one of the most common functional gastrointestinal disorders. It affects an estimated 10-15% of people in the United States, and more women experience it than men. IBS means there’s a disturbance in how your gut works, usually without visible signs of damage or disease on standard tests.

Common IBS symptoms include:

  • Recurrent abdominal pain or cramping
  • Bloating and gas
  • Changes in bowel habits
  • Low-grade inflammation (for some people)

Depending on which symptoms someone deals with the most, IBS is categorized into three main types:

  • IBS-C (IBS With Constipation): Predominantly constipation
  • IBS-D (IBS With Diarrhea): Predominantly diarrhea
  • IBS-M (Mixed IBS): Alternating between diarrhea and constipation (the worst of both worlds 🙃)

👉 TL;DR: IBS is more than an occasional stomachache. For many people, it can seriously disrupt daily life, making it tough to predict how they’ll feel from one day to the next. If you’re nodding along, you’re not alone.

The Gut Microbiome and IBS: What’s the Connection?

Your gut is home to trillions of microorganisms—bacteria, viruses, fungi, and more—collectively known as your gut microbiome. In a healthy gut, these microbes tend to coexist in a relatively balanced, well-regulated community. In many people with IBS, though, that balance is off-kilter, a state scientists call “dysbiosis.”

This microbial imbalance might contribute to IBS symptoms in several ways.3

Altered Gut Motility

Dysbiosis can disrupt the speed at which food moves through your digestive tract (called motility), and motility issues are common in IBS. Things may speed up and contribute to diarrhea, or slow way down and lead to constipation.

Gut microbes make compounds called metabolites that help regulate how your gut works, including how food moves along. So when that ecosystem is off, motility often follows.4

Increased Gut Sensitivity

An imbalanced microbiome can make the nerves in your gut more reactive, which scientists call visceral hypersensitivity.4 It means normal sensations like stretching or gas, which wouldn’t bother most people, can register as discomfort or pain.

It’s one of the reasons routine digestive processes that should feel normal can feel deeply uncomfortable for people with IBS.

Gut Barrier Dysfunction

The lining of your gut acts as a protective barrier. When that barrier becomes compromised, gaps can form that allow undigested food particles or microbial products to slip through into the bloodstream, potentially triggering immune responses and inflammation.

You might hear this called “leaky gut” or increased intestinal permeability.

Inflammation

Low-grade inflammation in the gut is common among people with IBS and can be both a cause and consequence of microbial imbalance.

Over time, this creates a cycle where inflammation and dysbiosis reinforce each other.4 That cycle is where probiotics for IBS might fit into the picture.

🔬 Science Translation: In IBS, an off-balance gut microbiome may speed up or slow down digestion, make gut nerves extra sensitive, weaken the gut lining, and help keep low-grade inflammation going.

How Can Probiotics Help With IBS?

Scientists define probiotics as “live microorganisms that, when administered in adequate amounts, confer a health benefit on the host.”5 Think of them as reinforcements that can help nudge your gut ecosystem back toward a more harmonious state. 🌿

Certain probiotics may help manage IBS symptoms by:6

  • Shifting the Balance: Adjusting the mix of microbes already in your gut ⚖️
  • Supporting Your Gut Lining: Helping keep your gut barrier strong and intact
  • Tuning Immune Responses: Influencing how your immune system responds and dialing down inflammation
  • Affecting Motility: Changing how your gut moves—and how it feels when it does

The Best Probiotics for IBS, by Symptom

Here are the strains that have been studied for specific IBS symptoms.

Probiotics for IBS-D (Diarrhea)

If frequent, urgent bathroom trips are your main concern, certain strains might be helpful:

  • Saccharomyces boulardii: When researchers reviewed studies in adults in 2010, this beneficial yeast showed benefits for several types of diarrhea across multiple trials. Its IBS evidence was one small trial, in which people had fewer stools a day.7 Clinical studies typically use 250–500 mg doses (approximately 5–10 billion CFU) daily.
  • Bacillus coagulans: In a small pilot trial in people with IBS-D, one strain (B. coagulans MTCC 5856) showed promise for symptoms including stool frequency and consistency. As a spore-former, it’s stable at room temperature. But more strain-specific trials are needed to confirm these effects in diverse IBS populations.8
  • Lacticaseibacillus rhamnosus GG (LGG): One of the most researched probiotic strains, L. rhamnosus GG shows potential for supporting overall gut health and managing diarrheal episodes, though more targeted studies are needed in people with IBS-D. In one lab study, in mini guts grown from human cells, LGG helped keep the gut lining intact against stool samples from people with IBS.9

Probiotics for IBS-C (Constipation)

Feeling blocked up and uncomfortable? The struggle is real. 💩 A couple of strains have been studied for regularity, though mostly in people without IBS:

  • Bifidobacterium animalis subsp. lactis HN019: In a 2018 trial of 228 adults with functional constipation (not IBS-C), this strain didn’t change colonic transit time—how quickly waste moves through—after four weeks. That was the trial’s main goal. But a second look at the data found more frequent bowel movements in people who started with three or fewer a week.10 The trial tested 1 billion and 10 billion CFU a day.
  • Bifidobacterium longum BB536: This strain has been studied for bowel regularity, mostly in general populations rather than in people with IBS-C.11,12 In healthy adults, it’s typically been studied at 2–5 billion CFU a day. Trials in older adults with constipation used 25–50 billion CFU.

Probiotics for IBS Bloating and Abdominal Pain

Bloating and pain are often the most bothersome IBS symptoms. These strains may help:

  • Lactiplantibacillus plantarum 299v: This strain has been studied in IBS, particularly for abdominal pain and bloating. In a 2012 trial, L. plantarum 299v lowered the severity and frequency of IBS-related pain.13 Research typically uses doses around 10 billion AFU or CFU.
  • Bifidobacterium infantis (aka B. longum subsp. infantis) 35624: In a four-week trial of 362 women with IBS, 100 million CFU of this strain beat placebo for pain, bloating, and bowel dysfunction. The lower and higher doses tested did no better than placebo.14 When researchers later pooled the trials, this strain on its own didn’t show a clear benefit for pain, bloating, or bowel habits. Combination products that included it did ease pain and bloating.15
  • Bifidobacterium bifidum MIMBb75: In a four-week trial of 122 adults with IBS, the live form beat placebo for overall symptom scores.16 A later eight-week trial, funded by the product’s maker, gave 443 adults a heat-inactivated (no longer alive) form. In that trial, 34% reached the main goal—at least 30% less belly pain plus overall symptoms that felt adequately better—versus 19% on placebo.17 Because probiotics are live by definition, scientists call heat-inactivated bacteria like these postbiotics instead.5,18

Can Probiotics Calm IBS-Related Inflammation?

Several Lactobacillus and Bifidobacterium strains show potential for supporting immune balance and reducing pro-inflammatory markers in the gut.19 Research here is still evolving, but it’s a promising direction for IBS management.

Best Probiotics for IBS: Quick Reference

Here’s how the strains compare, including the dose each was studied at and the kind of evidence behind it:

Probiotic Species or StrainStudied ForDose StudiedWhat the Research FoundEvidence
Bifidobacterium infantis 35624Pain, bloating, overall IBS~100 million CFUHelped at one dose of three; pooled single-strain trials: no clear benefit1 RCT in IBS (women); meta-analysis: mixed
Lactiplantibacillus plantarum 299vPain, bloating~10 billion CFULess pain and bloating than placeboRCT in IBS; low certainty overall
Bifidobacterium bifidum MIMBb75 (live or heat-inactivated)Pain, bloating, overall IBS~1 billion cellsBetter overall symptom scores2 RCTs in IBS
Bifidobacterium animalis subsp. lactis HN019Constipation (not IBS-C)1–10 billion CFUNo change in transit time (main goal)1 RCT in functional constipation
Bifidobacterium longum BB536Bowel regularity2–50 billion CFURegularity, mostly in general populationsReview
Saccharomyces boulardiiDiarrhea; IBS (one small trial)250–500 mg (5–10 billion CFU)Several types of diarrhea; fewer daily stools in one small IBS trialMeta-analysis in adults
Lacticaseibacillus rhamnosus GGIBS-D, general gut healthNot established for IBSGut-lining protection in lab-grown tissueLab study
Bacillus coagulansIBS-DVaries by formulationStool frequency and consistencySmall pilot RCT in IBS-D

How to read the Evidence column:

  • RCT = randomized controlled trial, where people get either the probiotic or a placebo (a look-alike with nothing active).
  • Meta-analysis = a study that pools the results of several trials.
  • Lab study = research on cells or tissue, not people.

Remember, these are general guidelines—individual responses vary. The “best” probiotic for you depends on your IBS subtype, your symptoms, and how your body responds.

How to Choose the Best Probiotic for IBS

Once you know which strains match your symptoms, a few label details help narrow the options.

Strain Specificity: Why the Full Strain Name Matters

Labels often list just Lactobacillus this or Bifidobacterium that. But when it comes to IBS, specific probiotic strains matter—not just species.

Think of it like hiring for a job: you don’t just need “an engineer,” you need one with specific skills for specific tasks. The same goes for probiotics; the right strain can make a difference, while a generic one might not. 🔬

Effects seen in a clinical study of L. rhamnosus GG, for example, can’t be assumed for every other Lactobacillus rhamnosus strain. Always look for the full strain designation (e.g., GG, 299v, BB536) on the label.

Clinical Dosages: Match the Amount Used in IBS Research

The amount of the probiotic strain, measured in Colony Forming Units (CFU) or Active Fluorescent Units (AFU), also matters. Benefits from studies are tied to specific dosages.14

Look for products that provide strains at levels consistent with IBS research. More ≠ better; the right amount of the right strain is what counts. 💊

Third-Party Testing: Is What’s on the Probiotic Label in the Bottle?

The FDA doesn’t approve over-the-counter probiotics, or their labels, before they’re sold. It does require makers to follow manufacturing and labeling rules, and it can act once a product is on the market.20

💡 Pro Tip: Look for a brand that uses independent, third-party testing for identity, potency, and contaminants, such as USP or NSF certification. Just remember: testing tells you the label is accurate—not that the strain helps IBS.

Survivability and Delivery: Ensuring Probiotics Reach Your Gut

Those beneficial microbes have a tough journey ahead—they need to survive stomach acid and bile salts to reach your intestines, where they can get to work. Some probiotics come in special capsules or formulations designed to protect them during this transit.

Multi-Strain vs. Single-Strain: Is One Better for IBS?

There’s ongoing discussion about whether multi-strain or single-strain probiotics work better, and the research doesn’t settle it.

In 2019, researchers reviewing 11 trials (eight of them testing blends) found benefits were clearer with multi-strain products taken for eight weeks or more.21 But a 2016 review of 21 trials found nearly the opposite: single strains, lower doses, and shorter courses did better for overall symptoms and quality of life.22

The largest analysis so far, a 2023 review of 82 trials, rated the evidence for blends as very low certainty for overall symptoms, pain, and bloating. Its strongest findings—still only moderate or low certainty—were for certain strains and groups of strains, such as L. plantarum 299v.1

Guidelines are cautious, too. A panel of Mexican gut specialists backs probiotics only as an add-on to other IBS care, and only conditionally, because the evidence is mixed.23

👉 TL;DR: Don’t get hung up on “single vs. multi.” Instead, look for clinical research supporting the exact formulation you’re considering—whether that’s a single strain or a multi-strain blend. More strains ≠ more evidence; the trial behind the formula is what matters most.

Probiotics and the Low FODMAP Diet

If you’re following a Low FODMAP diet to manage IBS symptoms, read probiotic ingredient lists as carefully as food labels. Some prebiotics commonly found in probiotic formulations—like inulin and fructooligosaccharides (FOS)—are high-FODMAP ingredients that could potentially trigger the symptoms you’re trying to avoid, especially during the elimination phase.19

Look for products that use:

  • Low FODMAP Prebiotics: Like certain resistant starches or polyphenol-based prebiotics
  • Prebiotic-Free Formulations: If you’re highly sensitive
  • Clear Labels for Prebiotic Sources: So you can cross-reference with your Low FODMAP guidelines

It’s a bit of homework, but if you’re sensitive to FODMAPs, choosing a compatible probiotic can make a big difference. A registered dietitian who specializes in IBS can also help identify probiotic options that align with your dietary restrictions.

Who Should Be Extra Cautious With Probiotics?

Probiotics are generally considered safe for most people, but certain people should take extra precautions or consult their doctor first:

  • Immunocompromised Individuals: In very rare cases, live bacteria can pose infection risks in severely immunocompromised individuals.24
  • Pregnant or Breastfeeding: Though probiotics are generally considered safe during pregnancy and lactation, confirm with your doctor or OB-GYN before adding anything new to your routine.
  • Recent Surgery or Serious Illness: Especially abdominal surgery or serious infections.
  • Drug Interactions to Consider: On immunosuppressant medications? Chat with your doctor.

These precautions aren’t meant to scare you—most people tolerate probiotics well. When in doubt, your provider is your best resource for personalized guidance. 🩺

Probiotic Side Effects With IBS: What to Expect When You Start

Don’t be surprised if your gut takes time to adjust. It’s common to experience mild, temporary changes during the adjustment period as your microbiome gets acquainted with the new arrivals.

Common initial effects of probiotics include:

These responses may actually be a good sign—they can mean the microbes are viable and actively interacting with your gut. Most people notice that they subside within a few days to a couple of weeks of consistent use.

If you’re prone to digestive sensitivity, try starting with a lower dose (if the product allows) or taking your probiotic with food, which can help buffer these early effects.

When to Take Probiotics for IBS

A few habits can help your probiotics work their best:

  • Consistency: Take your probiotic at the same time each day.
  • Experiment With Timing: When it comes to the best time to take probiotics, some people do better taking them with food; others prefer an empty stomach. See what works for you.
  • With Antibiotics: If you’ve been prescribed antibiotics, you can continue taking your probiotic—just take it 2–3 hours before or after your antibiotic dose to give the beneficial bacteria a better chance of survival.

The Bigger Picture: Probiotics as Part of an IBS Management Plan

While specific probiotics can be a valuable tool for managing IBS, they’re rarely a standalone solution. IBS is multifaceted, and a holistic approach usually works best. This might include:

  • Dietary Adjustments: Some people find relief with a low-FODMAP diet (under guidance), or by identifying trigger foods.25
  • Stress Management: Stress is a major IBS trigger. Techniques like mindfulness, yoga, or therapy may help.26
  • Working With a Healthcare Provider: Your doctor or a registered dietitian specializing in gut health can help you develop a comprehensive plan tailored to your specific IBS subtype and symptoms.

For example, if you’re adding more fiber for IBS-C, ask your provider whether a strain studied for constipation, like B. lactis HN019, fits alongside it. Just know that its trial was in people with functional constipation, not IBS-C.10

Or maybe stress is your primary IBS trigger. In that case, certain strains with documented effects on the gut-brain axis might be valuable alongside something like therapy.

The Key Insight

Navigating IBS is challenging, and certain probiotics may help ease specific symptoms. Move past generic claims and focus on specific, clinically studied strains and formulations that match your symptoms—diarrhea, constipation, bloating, or pain.

Consistency matters, too, because these microbial allies work through transient interactions within your gut.

Choosing a probiotic wisely, understanding that an initial adjustment period is normal, and adding probiotics to a broader IBS management strategy under your doctor’s guidance may make a meaningful difference.

Good health isn’t hacked—it’s cultured, and that includes nurturing your gut microbiome with precision and patience. 🌱

Frequently Asked Questions (FAQs)

Can Probiotics Actually Make IBS Worse Initially?

It’s possible. Some people with IBS experience a temporary increase in gas, bloating, or changes in bowel habits when they first start taking probiotics. This is normal—it’s part of an adjustment period as your gut microbiome adapts to the new strains.

The good news: these side effects are typically mild and tend to resolve within a few days to a couple of weeks with continued use.

How Long Does It Take for Probiotics to Help IBS Symptoms?

It depends. How long probiotics take to work varies with the specific probiotic strain(s), the dosage, and the symptoms being targeted. Some people notice improvements within a few weeks, while others may need a month or more of consistent daily use.6

In several clinical trials of probiotics for IBS, people took a probiotic daily for about 4 to 12 weeks.14,16,27 So a fair test looks similar: pick one product, take it as directed for at least a month, and track your symptoms. If nothing has changed by about 12 weeks, stop and check in with your provider.

Should I Take Probiotics Every Day for IBS?

Generally, yes. Since most probiotics are transient and don’t permanently settle in the gut, consistent daily intake is usually necessary to maintain their potential benefits for IBS symptoms.28

Always follow the product’s recommended dosage and consult your healthcare provider.

What’s the Difference Between Spore-Based Probiotics and Regular Probiotics?

It comes down to how they survive the journey to your gut.

Traditional probiotics (most Lactobacillus and Bifidobacterium strains) are live bacteria that often need specialized capsules or coatings to survive stomach acid.

Spore-based probiotics (e.g., from the Bacillus genus) form protective spores that are naturally resistant to harsh conditions. This difference tends to make them shelf-stable.8

💡 Pro Tip: When choosing between them, focus less on delivery format and more on whether the product’s strains have been studied for your specific symptoms.

Citations

  1. Goodoory, V. C., Khasawneh, M., Black, C. J., Quigley, E. M. M., Moayyedi, P., Ford, A. C. (2023). Efficacy of probiotics in irritable bowel syndrome: Systematic review and meta-analysis. Gastroenterology, 165(5):1206–18. https://doi.org/10.1053/j.gastro.2023.07.018
  2. Ballena-Caicedo, J., Zuzunaga-Montoya, F. E., Acosta-Porzoliz, R., García-Ahumada, F., Rivera-Lozada, O., Valladares-Garrido, M. J., Vera-Ponce, V. J. (2026). Probiotics in irritable bowel syndrome: An umbrella review of 27 systematic reviews on methodological quality and certainty of evidence. Journal of Clinical Medicine, 15(5):1727. https://doi.org/10.3390/jcm15051727
  3. Principi, N., Cozzali, R., Farinelli, E., Brusaferro, A., Esposito, S. (2018). Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics. Journal of Infection, 76(2):111–20. https://doi.org/10.1016/j.jinf.2017.12.013
  4. Cheng, X., Ren, C., Mei, X., Jiang, Y., Zhou, Y. (2024). Gut microbiota and irritable bowel syndrome: status and prospect. Frontiers in Medicine, 11:1429133. https://doi.org/10.3389/fmed.2024.1429133
  5. Hill, C., Guarner, F., Reid, G., Gibson, G. R., Merenstein, D. J., Pot, B., Morelli, L., Canani, R. B., Flint, H. J., Salminen, S., Calder, P. C., Sanders, M. E. (2014). Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology, 11(8):506–14. https://doi.org/10.1038/nrgastro.2014.66
  6. Didari, T., Mozaffari, S., Nikfar, S., Abdollahi, M. (2015). Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis. World Journal of Gastroenterology, 21(10):3072–84. https://doi.org/10.3748/wjg.v21.i10.3072
  7. McFarland, L. V. (2010). Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World Journal of Gastroenterology, 16(18):2202–22. https://doi.org/10.3748/wjg.v16.i18.2202
  8. Majeed, M., Nagabhushanam, K., Natarajan, S., Sivakumar, A., Ali, F., Pande, A., Majeed, S., Karri, S. K. (2016). Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study. Nutrition Journal, 15:21. https://doi.org/10.1186/s12937-016-0140-6
  9. Han, X., Lee, A., Huang, S., Gao, J., Spence, J. R., Owyang, C. (2019). Lactobacillus rhamnosus GG prevents epithelial barrier dysfunction induced by interferon-gamma and fecal supernatants from irritable bowel syndrome patients in human intestinal enteroids and colonoids. Gut Microbes, 10(1):59–76. https://doi.org/10.1080/19490976.2018.1479625
  10. Ibarra, A., Latreille-Barbier, M., Donazzolo, Y., Pelletier, X., Ouwehand, A. C. (2018). Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial. Gut Microbes, 9(3):236–51. https://doi.org/10.1080/19490976.2017.1412908
  11. Wong, C. B., Odamaki, T., Xiao, J. Z. (2019). Beneficial effects of Bifidobacterium longum subsp. longum BB536 on human health: Modulation of gut microbiome as the principal action. Journal of Functional Foods, 54:506–19. https://doi.org/10.1016/j.jff.2019.02.002
  12. Takeda, T., Asaoka, D., Nojiri, S., Yanagisawa, N., Nishizaki, Y., Osada, T., Koido, S., Nagahara, A., Katsumata, N., Odamaki, T., Xiao, J. Z., Ohkusa, T., Sato, N. (2023). Usefulness of Bifidobacterium longum BB536 in elderly individuals with chronic constipation: A randomized controlled trial. The American Journal of Gastroenterology, 118(3):561–8. https://doi.org/10.14309/ajg.0000000000002028
  13. Ducrotté, P., Sawant, P., Jayanthi, V. (2012). Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome. World Journal of Gastroenterology, 18(30):4012–8. https://doi.org/10.3748/wjg.v18.i30.4012
  14. Whorwell, P. J., Altringer, L., Morel, J., Bond, Y., Charbonneau, D., O’Mahony, L., Kiely, B., Shanahan, F., Quigley, E. M. (2006). Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. The American Journal of Gastroenterology, 101(7):1581–90. https://doi.org/10.1111/j.1572-0241.2006.00734.x
  15. Yuan, F., Ni, H., Asche, C. V., Kim, M., Walayat, S., Ren, J. (2017). Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis. Current Medical Research & Opinion, 33(7):1191–7. https://doi.org/10.1080/03007995.2017.1292230
  16. Guglielmetti, S., Mora, D., Gschwender, M., Popp, K. (2011). Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life—a double-blind, placebo-controlled study. Alimentary Pharmacology & Therapeutics, 33(10):1123–32. https://doi.org/10.1111/j.1365-2036.2011.04633.x
  17. Andresen, V., Gschossmann, J., Layer, P. (2020). Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial. Lancet Gastroenterology & Hepatology, 5(7):658–66. https://doi.org/10.1016/S2468-1253(20)30056-X
  18. Salminen, S., Collado, M. C., Endo, A., Hill, C., Lebeer, S., Quigley, E. M. M., Sanders, M. E., Shamir, R., Swann, J. R., Szajewska, H., Vinderola, G. (2021). The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nature Reviews Gastroenterology & Hepatology, 18(9):649–67. https://doi.org/10.1038/s41575-021-00440-6
  19. Rau, S., Gregg, A., Yaceczko, S., Limketkai, B. (2024). Prebiotics and Probiotics for Gastrointestinal Disorders. Nutrients, 16(6):778. https://doi.org/10.3390/nu16060778
  20. U.S. Food and Drug Administration. (2026). Questions and answers on dietary supplements. FDA.gov. https://www.fda.gov/food/information-consumers-using-dietary-supplements/questions-and-answers-dietary-supplements
  21. Dale, H. F., Rasmussen, S. H., Asiller, Ö. Ö., Lied, G. A. (2019). Probiotics in Irritable Bowel Syndrome: An Up-to-Date Systematic Review. Nutrients, 11(9):2048. https://doi.org/10.3390/nu11092048
  22. Zhang, Y., Li, L., Guo, C., Mu, D., Feng, B., Zuo, X., Li, Y. (2016). Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis. BMC Gastroenterology, 16(1):62. https://doi.org/10.1186/s12876-016-0470-z
  23. Remes-Troche, J. M., Coss-Adame, E., Schmulson, M., García-Zermeño, K. R., Amieva-Balmori, M., Carmona-Sánchez, R., Gómez-Escudero, O., Gómez-Castaños, P. C., Icaza-Chávez, M. E., López-Colombo, A., Morel-Cerda, E. C., Valdovinos-Díaz, M. Á., Valdovinos-García, L. R., Villar-Chávez, A. S. (2025). Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociación Mexicana de Gastroenterología, 2024. Revista de Gastroenterología de México (English Edition), 90(1):77–110. https://doi.org/10.1016/j.rgmxen.2024.10.009
  24. Doron, S. & Snydman, D. R. (2015). Risk and safety of probiotics. Clinical Infectious Diseases, 60(S2):S129–34. https://doi.org/10.1093/cid/civ085
  25. McKenzie, Y. A., Bowyer, R. K., Leach, H., Gulia, P., Horobin, J., O’Sullivan, N. A., Pettitt, C., Reeves, L. B., Seamark, L., Williams, M., Thompson, J., Lomer, M. C. E. (2016). British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). Journal of Human Nutrition & Dietetics, 29(5):549–75. https://doi.org/10.1111/jhn.12385
  26. Adriani, A., Ribaldone, D. G., Astegiano, M., Durazzo, M., Saracco, G. M., Pellicano, R. (2018). Irritable bowel syndrome: the clinical approach. Panminerva Medica, 60(4):213–22. https://doi.org/10.23736/S0031-0808.18.03541-3
  27. Ghoshal, U. C., Ramakrishna, B. S., Rathi, P. M., Shukla, A., Panigrahi, M. K., Jain, S., Saha, I., Chakravartty, K., Singh, M., Mustafa, U., Sahu, S., Ghoshal, U., Chandnani, S., Goenka, M. K., Mitra, M. (2026). Probiotic blend of Lactobacillus acidophilus LA-5 and Bifidobacterium animalis ssp. lactis BB-12 in non-constipated irritable bowel syndrome: A double-blind randomized placebo-controlled trial. Journal of Gastroenterology & Hepatology, 41(1):140–54. https://doi.org/10.1111/jgh.70137
  28. Derrien, M. & van Hylckama Vlieg, J. E. T. (2015). Fate, activity, and impact of ingested bacteria within the human gut microbiota. Trends in Microbiology, 23(6):354–66. https://doi.org/10.1016/j.tim.2015.03.002